viewArcadia Biosciences Inc

Arcadia Biosciences shares pop after receiving industrial hemp license in Hawaii

The license allows for the cultivation of industrial hemp in Hawaii for the purpose of research

hemp field
Hemp and hemp products produced under the Hawaiian program can be sold commercially

Shares of Arcadia Biosciences (NASDAQ:RKDA) rocketed Monday after the agricultural food ingredient company announced it has been granted an industrial hemp pilot program license by Hawaii’s Department of Agriculture.

The license will allow Arcadia to continue its new push into the hemp market as it permits the cultivation of industrial hemp in Hawaii for the purpose of agricultural and academic research. Hemp and hemp products produced under the program can be sold commercially.

In response to the news, investors sent Arcadia shares up 24.8% to $9.00 before the opening bell on Monday.

READ: Arcadia Biosciences shares soar on move into cannabis business

The Davis, California-based company announced last week that it has launched a unit, Arcadia Specialty Genomics, to focus on the genetic improvement of cannabis, hemp and other crops.

With this license, Hawaii becomes the first state where Arcadia Specialty Genomics will kick off its research and cultivation of hemp, planting on ten acres of recently-leased land next month.

The combination of the license and the cultivation facility underline Arcadia’s move to leverage its expertise as a science-driven company and genetics innovator in food crops into legal cannabis markets.

“As the only company working in the cannabis industry with a proven track record of improving plants and commercializing food ingredients from agricultural products using non-GM techniques, we’re ideally positioned to help hemp growers and end-users benefit from better hemp strains,” said Matt Plavan, CFO of Arcadia Biosciences and president of Arcadia Specialty Genomics.

“Being licensed by the state of Hawaii to participate in this highly selective program gives us an important head start and we’re moving quickly to establish our Hawaii research program immediately as we pursue expansion through licenses in other states,” Plavan added.

READ: Arcadia Biosciences CEO offers time line for getting new products to market

Arcadia’s move to apply its expertise in crop improvement to cannabis and hemp, with an initial focus on the hemp market, comes at a time when the cannabis market is burgeoning.

The recent passage of the US Farm Bill, which legalizes the commercial production of hemp and spurs the growth of cannabidiols (CBD), creates considerable opportunity for Arcadia.

Arcadia Specialty Genomics will develop new cannabis and hemp varieties that are more productive and more resistant to pests that can be licensed to cultivators and used for nutraceutical and food-based products.

Such developments are made possible through Arcadia’s approach, which combines conventional breeding, advanced screening as well as gene editing. Through this process, plant populations carrying desirable genetic characteristics are identified, isolated and bred to reproduce.

Contact Ellen Kelleher at ellen@proactiveinvestors.com

Quick facts: Arcadia Biosciences Inc

Price: 3.28 USD

Market: NASDAQ
Market Cap: $35.09 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...


Full interview: Arcadia Biosciences records some big wins in the 3rd Quarter

Arcadia Biosciences (NASDAQ: RKDA) CEP Matt Plavan joined Proactive’s Steve Darling to discuss the company’s third-quarter results. Plavan also discussed some of the company highlights during that quarter including the latest on their research facilities. Plavan also discussed their hemp...

on 7/11/19

3 min read